The Medicon Valley Inhalation Consortium (MVIC) announced that marketing specialist Mats Håkansson will take over the CEO role from Lars Asking. According to the announcement, Asking, who had served as the CEO of MVIC since 2017, will continue to lead projects for the consortium, which acts as a contract research organization.
According to Håkansson’s LinkedIn page, he has served in executive positions in several cannabis-focused companies, most recently as CEO of a medical cannabis start-up. His past experience also includes sales and marketing positions at companies such as Viropharma, Niconovum, and Novo Nordisk.
MVIC currently includes 20 member companies and offers a variety of inhalation formulation characterization and development services. The consortium also sponsors the annual Medicon Valley Inhalation Symposium (MVIS).
Read the MVIC announcement.
